Cytomegalovirus (CMV) causes life-threatening disseminated infections and in particular
vision-threatening infections of the retina in patients with the acquired immunodeficiency …

Cytomegalovirus (CMV) encephalitis has been reported with increasing frequency in
patients with AIDS. Nevertheless, the management of CMV-related encephalitis appears to …

Infections caused by cytomegalovirus (CMV) resistantin vitroto ganciclovir, defined as
requiring> 6 µmol of ganciclovir for ED50 have developed in some AIDS patients with …

Ten patients with acquired immunodeficiency syndrome with newly diagnosed
cytomegalovirus (CMV) retinitis were treated with an induction regimen of intravenous …

Ganciclovir and foscarnet are both effective for cytomegalovirus retinitis in patients with
acquired immunodeficiency syndrome, but the benefits of either agent given alone are …

The use of ganciclovir in the treatment of cytomegalovirus (CMV) retinitis in patients with
acquired immunodeficiency syndrome (AIDS) is limited by marrow toxicity and by the …

A total of 314 immunocompromised patients with serious cytomegalovirus (CMV) infection
treated with ganciclovir administered intravenously were studied. Rates of favorable clinical …

Both ganciclovir, a nucleoside analogue, and foscarnet, a pyrophosphate analogue,
specifically bind cytomegalovirus (CMV) DNA polymerase and inhibit CMV replication at …

Objectives: To compare the safety and efficacy of oral ganciclovir with intravenous
ganciclovir for the maintenance therapy of cytomegalovirus (CMV) retinitis in AIDS patients …

AIDS patients with newly diagnosed cytomegalovirus (CMV) retinitis who had just completed
a 14-day course of ganciclovir induction therapy were randomly assigned to an alternating …